Clinical Trials Browser

Phase 3 × Standard of Care × Gastrointestinal × Clear all

NCT06563388 2026-02-04

ID-COMET

Phase 3 Recruiting

GastrointestinalGenitourinaryThoracic

Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms

NCT05865743 2025-03-05

PERSuaDER

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06857773 2025-03-04

PUMP-IT RCT

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06646809 2024-10-17

RISIS-CR

Phase 3 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06391892 2024-04-30

LIQUIPANC

Phase 3 Recruiting

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT00003674 2016-07-13

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Phase 3 Completed

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT00355355 2015-01-30

A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms